Torsemide 100 MG Oral Tablet — RxCUI 198370
RxNorm drug concept · Semantic clinical drug
RxCUI 198370
Semantic clinical drug · SCD
● Current RxNorm concept 41 FDA products
64 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198370
Official nameTorsemide 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped41
Package NDCs mapped64
Reported Medicaid activity (SDUD)297,073 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Torsemide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, increased urination is the whole point — but it's doing so for a reason. Torsemide blocks your kidneys from reabsorbing sodium and water, so your body flushes out extra fluid....
- What exactly is torsemide doing for me — is it just making me urinate more?
- Most people take it in the morning, and that's the practical advice. Because it causes increased urination for several hours, taking it at night can disrupt your sleep. You can tak...
- When should I take torsemide — does it matter what time of day?
🕸️ Concept Web — How Torsemide 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Torsemide 100 MG Oral Tablet
RxCUI 198370 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Torsemide
38413IN
-
Torsemide
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Torsemide Oral Tablet
374168SCDF -
Torsemide Oral Product
1162752SCDG -
Torsemide Pill
1162753SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Torsemide Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Torsemide 100 MG
316844SCDC
-
Torsemide 100 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Torsemide 100 MG
SCDC · 316844 -
Torsemide Oral Tablet
SCDF · 374168 -
Torsemide Oral Product
SCDG · 1162752 -
Torsemide Pill
SCDG · 1162753
📦 FDA Products & Package NDCs
41 products · 64 package NDCs
64 package NDCs map to RxCUI 198370 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 23155-0871-01 | 100 TABLET in 1 BOTTLE (23155-871-01) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0871-05 | 500 TABLET in 1 BOTTLE (23155-871-05) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0871-10 | 1000 TABLET in 1 BOTTLE (23155-871-10) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0872-01 | 100 TABLET in 1 BOTTLE (23155-872-01) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0872-05 | 500 TABLET in 1 BOTTLE (23155-872-05) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0872-10 | 1000 TABLET in 1 BOTTLE (23155-872-10) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0873-01 | 100 TABLET in 1 BOTTLE (23155-873-01) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0873-05 | 500 TABLET in 1 BOTTLE (23155-873-05) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0873-10 | 1000 TABLET in 1 BOTTLE (23155-873-10) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0874-01 | 100 TABLET in 1 BOTTLE (23155-874-01) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0874-05 | 500 TABLET in 1 BOTTLE (23155-874-05) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 23155-0874-10 | 1000 TABLET in 1 BOTTLE (23155-874-10) | Torsemide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-07-24 |
| 31722-0529-01 | 100 TABLET in 1 BOTTLE (31722-529-01) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 31722-0529-05 | 500 TABLET in 1 BOTTLE (31722-529-05) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 31722-0530-01 | 100 TABLET in 1 BOTTLE (31722-530-01) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 31722-0530-05 | 500 TABLET in 1 BOTTLE (31722-530-05) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 31722-0531-01 | 100 TABLET in 1 BOTTLE (31722-531-01) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 31722-0531-05 | 500 TABLET in 1 BOTTLE (31722-531-05) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 31722-0532-01 | 100 TABLET in 1 BOTTLE (31722-532-01) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 31722-0532-05 | 500 TABLET in 1 BOTTLE (31722-532-05) | Torsemide | Camber Pharmaceuticals, Inc. | 2011-01-01 |
| 42291-0816-90 | 90 TABLET in 1 BOTTLE (42291-816-90) | Torsemide | AvKARE | 2017-04-03 |
| 42291-0817-90 | 90 TABLET in 1 BOTTLE (42291-817-90) | Torsemide | AvKARE | 2017-04-03 |
| 42291-0818-01 | 100 TABLET in 1 BOTTLE (42291-818-01) | Torsemide | AvKARE | 2023-03-15 |
| 42291-0818-50 | 500 TABLET in 1 BOTTLE (42291-818-50) | Torsemide | AvKARE | 2023-03-15 |
| 42291-0818-90 | 90 TABLET in 1 BOTTLE (42291-818-90) | Torsemide | AvKARE | 2017-04-03 |
| 42291-0819-90 | 90 TABLET in 1 BOTTLE (42291-819-90) | Torsemide | AvKARE | 2014-12-30 |
| 50090-6495-00 | 90 TABLET in 1 BOTTLE (50090-6495-0) | Torsemide | A-S Medication Solutions | 2023-05-23 |
| 50090-7425-00 | 90 TABLET in 1 BOTTLE (50090-7425-0) | Torsemide | A-S Medication Solutions | 2024-10-29 |
| 50111-0915-01 | 100 TABLET in 1 BOTTLE (50111-915-01) | Torsemide | Teva Pharmaceuticals USA, Inc. | 2004-06-01 |
| 50111-0916-01 | 100 TABLET in 1 BOTTLE (50111-916-01) | Torsemide | Teva Pharmaceuticals USA, Inc. | 2004-06-01 |
| 50111-0917-01 | 100 TABLET in 1 BOTTLE (50111-917-01) | Torsemide | Teva Pharmaceuticals USA, Inc. | 2004-06-01 |
| 50111-0917-03 | 1000 TABLET in 1 BOTTLE (50111-917-03) | Torsemide | Teva Pharmaceuticals USA, Inc. | 2004-06-01 |
| 50111-0918-01 | 100 TABLET in 1 BOTTLE (50111-918-01) | Torsemide | Teva Pharmaceuticals USA, Inc. | 2004-10-20 |
| 50268-0754-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-754-15) / 1 TABL... | Torsemide | AvPAK | 2014-10-07 |
| 50268-0755-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-755-15) / 1 TABL... | Torsemide | AvPAK | 2014-10-07 |
| 50268-0756-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-756-15) / 1 TABL... | Torsemide | AvPAK | 2014-10-07 |
| 50268-0757-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-757-15) / 1 TABL... | Torsemide | AvPAK | 2014-10-07 |
| 51407-0596-90 | 90 TABLET in 1 BOTTLE (51407-596-90) | Torsemide | Golden State Medical Supply, Inc. | 2024-08-29 |
| 51407-0597-90 | 90 TABLET in 1 BOTTLE (51407-597-90) | Torsemide | Golden State Medical Supply, Inc. | 2024-08-29 |
| 51407-0598-90 | 90 TABLET in 1 BOTTLE (51407-598-90) | Torsemide | Golden State Medical Supply, Inc. | 2024-08-29 |
| 57237-0138-01 | 100 TABLET in 1 BOTTLE (57237-138-01) | Torsemide | Rising Pharma Holdings, Inc. | 2007-10-17 |
| 57237-0139-01 | 100 TABLET in 1 BOTTLE (57237-139-01) | Torsemide | Rising Pharma Holdings, Inc. | 2007-10-17 |
| 57237-0140-01 | 100 TABLET in 1 BOTTLE (57237-140-01) | Torsemide | Rising Pharma Holdings, Inc. | 2007-10-17 |
| 57237-0141-01 | 100 TABLET in 1 BOTTLE (57237-141-01) | Torsemide | Rising Pharma Holdings, Inc. | 2007-10-17 |
| 62135-0818-90 | 90 TABLET in 1 BOTTLE (62135-818-90) | Torsemide | Chartwell RX, LLC | 2024-01-17 |
| 62135-0819-90 | 90 TABLET in 1 BOTTLE (62135-819-90) | Torsemide | Chartwell RX, LLC | 2024-01-17 |
| 62135-0820-90 | 90 TABLET in 1 BOTTLE (62135-820-90) | Torsemide | Chartwell RX, LLC | 2024-01-17 |
| 62135-0821-90 | 90 TABLET in 1 BOTTLE (62135-821-90) | Torsemide | Chartwell RX, LLC | 2024-01-17 |
| 65862-0125-01 | 100 TABLET in 1 BOTTLE (65862-125-01) | Torsemide | Aurobindo Pharma Limited | 2007-10-17 |
| 65862-0125-99 | 1000 TABLET in 1 BOTTLE (65862-125-99) | Torsemide | Aurobindo Pharma Limited | 2007-10-17 |
Observed labelers:
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (12) ·
Aurobindo Pharma Limited (8) ·
Camber Pharmaceuticals, Inc. (8) ·
XLCare Pharmaceuticals Inc. (8) ·
AvKARE (6) ·
Teva Pharmaceuticals USA, Inc. (5)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.